InsidersTradesSigma
Browse the full record of transactions filed by WILSON JAMES N, Director. Officer active across 1 companies, notably CORCEPT THERAPEUTICS INC. Cumulatively, 2 disclosures have been published. The latest transaction was filed on 14 June 2022 — Levée d'options. Regulator: SEC (Form 4). The full history is openly available.
2 of 2 declarations
James N. Wilson is a Board Member at Corcept Therapeutics Inc. He brings valuable expertise in biotechnology and research. His role involves overseeing the company's strategies and ensuring compliance with industry standards. James contributes to strategic decision-making that influences innovation and growth at Corcept.